Literature DB >> 6966321

Self H-2 antigens influence the specificity of alloreactive cells.

T Hünig, M J Bevan.   

Abstract

We have tested Jerne's hypothesis (9) that the phenomenon alloreactivity is explained by the existence of T cells that express germline-encoded receptors specific for major histocompatibility complex antigens and that these cells undergo no change in specificity during thymic differentiation. T cells from [F1 leads to Parent] bone marrow radiation chimeras reactive to conventional antigens are known to have a self preference, i.e., [A X B leads to A] chimeras respond better to H-2A-plus-antigen than to H-2B-plus-antigen. We show here that alloreactive cells from such chimeras also have a self preference. Thus, H-2k-specific alloreactive T cells from [H-2b X H-2d leads to H-2b] and [H-2b X H-2d leads to H-2d] chimeras cross-react more on TNP-modified H-2b or H-2d targets, respectively. In contrast to Jerne's prediction, the results suggest that the receptor repertoire of alloreactive F1 cells is influenced by H-2 antigens on radiation-resistant cells present during T cell ontogeny. By this criterion of having a self preference in H-2 restriction, alloreactive T cells appear to be similar to T cells that respond to conventional antigens.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6966321      PMCID: PMC2185845          DOI: 10.1084/jem.151.5.1288

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

Review 1.  The somatic generation of immune recognition.

Authors:  N K Jerne
Journal:  Eur J Immunol       Date:  1971-01       Impact factor: 5.532

2.  Killer cells reactive to altered-self antigens can also be alloreactive.

Authors:  M J Bevan
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

3.  Cell-mediated cytotoxicity to trinitrophenyl-modified syngeneic lymphocytes.

Authors:  G M Shearer
Journal:  Eur J Immunol       Date:  1974-08       Impact factor: 5.532

4.  Antigen-binding, idiotypic T-lymphocyte receptors.

Authors:  H Binz; H Wigzell
Journal:  Contemp Top Immunobiol       Date:  1977

5.  Role of the murine major histocompatibility complex in the specificity of in vitro T-cell-mediated lympholysis against chemically-modified autologous lymphocytes.

Authors:  G M Shearer; T G Rehn; A M Schmitt-Verhulst
Journal:  Transplant Rev       Date:  1976

6.  Specificity of virus-immune effector T cells for H-2K or H-2D compatible interactions: implications for H-antigen diversity.

Authors:  P C Doherty; R V Blanden; R M Zinkernagel
Journal:  Transplant Rev       Date:  1976

7.  Shared idiotypic determinants on B and T lymphocytes reactive against the same antigenic determinants. II. Determination of frequency and characteristics of idiotypic T and B lymphocytes in normal rats using direct visualization.

Authors:  H Binz; H Wigzell
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

8.  Early cellular events in a systemic graft-vs.-host reaction. II. Autoradiographic estimates of the frequency of donor lymphocytes which respond to each Ag-B-determined antigenic complex.

Authors:  W L Ford; S J Simmonds; R C Atkins
Journal:  J Exp Med       Date:  1975-03-01       Impact factor: 14.307

9.  In vitro cell-mediated immune responses to the male specific(H-Y) antigen in mice.

Authors:  R D Gordon; E Simpson; L E Samelson
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

10.  The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens.

Authors:  M J Bevan
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

View more
  12 in total

1.  Involvement of I-J epitopes in the self- and allo-recognition sites of T cells: blocking of syngeneic and allogeneic mixed lymphocyte reaction-responder cells by monoclonal anti-I-J antibodies.

Authors:  W Uracz; R Abe; T Tada
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

2.  Clonal analysis of the specificity of alloreactive cells: "dominance" of E beta reactive clones.

Authors:  G Pobor; S Pettersson; A Coutinho
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

Review 3.  Internal images of antigens within the immune network.

Authors:  A A Augustin; G K Sim; C A Bona
Journal:  Surv Immunol Res       Date:  1983

4.  T cells respond preferentially to antigens that are similar to self H-2.

Authors:  M J Bevan; T Hünig
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

5.  Major histocompatibility restriction of antigen recognition by T cells in a recipient of haplotype mismatched human bone marrow transplantation.

Authors:  E Chu; D Umetsu; F Rosen; R S Geha
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

6.  Cooperation between major histocompatibility complex mismatched mononuclear cells from a human chimera in the production of antigen-specific antibody.

Authors:  M G Roncarolo; J L Touraine; J Banchereau
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

7.  Influence of the major histocompatibility complex on the repertoire of allospecific cytolytic T lymphocytes.

Authors:  L A Sherman
Journal:  J Exp Med       Date:  1982-02-01       Impact factor: 14.307

8.  Antigen recognition by cloned cytotoxic T lymphocytes follows rules predicted by the altered-self hypothesis.

Authors:  T R Hünig; M J Bevan
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

9.  Tolerance of thymocytes to allogeneic I region determinants encountered prethymically. Evidence for expression of anti-Ia receptors by T cell precursors before their entry into the thymus.

Authors:  S M Bradley; P J Morrissey; S O Sharrow; A Singer
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

10.  Specificity of cytotoxic T cells from athymic mice.

Authors:  T Hünig; M J Bevan
Journal:  J Exp Med       Date:  1980-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.